Product Information
LITHIUM CARBONATE ER 450 MG TB is a generic product labeled by Glenmark Pharmaceuticals Inc., USA, priced at $0.2543 per EA under NDC 68462022401. Its NADAC has been published 665 times since Nov 28, 2013.
FDA first approved this application on Feb 14, 2011. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
450 mg/1
Manufacturer
Glenmark Pharmaceuticals Inc., USANDC
68462022401
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
LITHIUM CARBONATEApproval Type
Generic (ANDA)
FDA Application
ANDA091616FDA Approved
2/14/2011
TE Code
AB
On Market Since
2/14/2011
Pharmacological Classes
Price Statistics
The NADAC for LITHIUM CARBONATE ER 450 MG TB has been published 665 times since Nov 28, 2013, and over the history we have for it it has declined 12.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2543 per EA |
|---|---|
| All-time high | $0.3116 (Jun 11, 2014) |
| All-time low | $0.1550 (Jul 20, 2022) |
| 52-week high | $0.2641 |
| 52-week low | $0.2474 |
| Median price | $0.2340 |
| Average price | $0.2356 |
| Largest weekly change | -37.9% (Nov 20, 2024) |
| Weeks tracked | 665 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of LITHIUM CARBONATE ER 450 MG TB?
The current National Average Drug Acquisition Cost (NADAC) for LITHIUM CARBONATE ER 450 MG TB, manufactured by Glenmark Pharmaceuticals Inc., USA, is $0.2543 per EA (NDC 68462022401), effective Aug 19, 2026.
How has the price of LITHIUM CARBONATE ER 450 MG TB changed over time?
Over the history we have for it, the NADAC for LITHIUM CARBONATE ER 450 MG TB has declined 12.1%. It has been tracked across 665 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for LITHIUM CARBONATE ER 450 MG TB?
Since Nov 28, 2013, the NADAC for LITHIUM CARBONATE ER 450 MG TB has ranged from a low of $0.1550 (Jul 20, 2022) to a high of $0.3116 (Jun 11, 2014), with a median of $0.2340 per EA.
Are there cheaper alternatives to LITHIUM CARBONATE ER 450 MG TB?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as LITHIUM CARBONATE ER 450 MG TB in a comparable dosage form, but none are currently priced below it.
Who manufactures LITHIUM CARBONATE ER 450 MG TB?
LITHIUM CARBONATE ER 450 MG TB (NDC 68462022401) is labeled by Glenmark Pharmaceuticals Inc., USA, and CMS classifies it as a generic product.